Article
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 2006
Wang Luo, Wei Qingyi, Wang Li-E, Aldape Kenneth D, Cao Yumei, Okcu M Fatih, Hess Kenneth R, El-Zein Randa, Gilbert Mark R, Woo Shiao Y, Prabhu Sujit S, Fuller Greg N, Bondy Melissa L
Abstract excerpt
PURPOSE: Glioblastoma multiforme (GBM) is the most common and aggressive glioma with the poorest survival. Use of biomarkers for screening patients with GBM may be used to modify treatments and improve outcomes. The level of human telomerase (hTERT) expression is an independent predictor of outco...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
